HMT, led by Partner Paul Read, advised Agathos on their investment in fast-growing healthcare recruitment business Hunter Healthcare to back the management buyout.
Hunter is a London-headquartered, specialist healthcare recruitment business that places interim and permanent candidates into roles in the NHS, private healthcare and life science sectors. Hunter is known for its niche sector focus, high calibre candidates, depth of market knowledge, and the strength of its relationships with clients.
Hunter is active in the field of healthcare recruitment for non-clinical roles, with revenues growing to £44m in the current financial year. The company is supporting the NHS with its reorganisation of Integrated Care Systems, the elective care backlog, and the continued shift towards digitalisation.
The Agathos investment will facilitate the management buy-out of Hunter Healthcare and support the senior leadership team in delivering ambitious growth plans. Internationally, Hunter has started serving the diagnostic and medical devices sector in the USA and plans on building its footprint in these fast-growing market segments over the months ahead.
HMT undertook financial due diligence for Agathos on this transaction.
Established in 1992, HMT is an independent adviser in the South of England and London, advising on all aspects of corporate finance transactions including lead advisory, due diligence, debt advisory, financial modelling and transactional tax. HMT’s clients include management teams, privately-owned businesses, private equity investors, public companies and debt providers. Since 1992, HMT has advised on over 500 deals with an aggregate value in excess of £5 billion.
HTM has offices in Henley-on-Thames, Oxfordshire and London.